Effects of oxysterols on the blood-brain barrier: Implications for Alzheimer's disease

被引:52
|
作者
Gosselet, Fabien
Saint-Pol, Julien
Fenart, Laurence
机构
[1] Univ Lille Nord France, Lille, France
[2] UArtois, LBHE, EA 2465, Lens, France
[3] IMPRT IFR114, Lille, France
关键词
Oxysterols; Blood-brain barrier; ABCA1; ABCB1; Alzheimer's disease; LXR; CAPILLARY ENDOTHELIAL-CELLS; AMYLOID-BETA-PEPTIDE; BODY CHOLESTEROL METABOLISM; TO-BASOLATERAL TRANSPORT; TRANSGENIC MOUSE MODEL; P-GLYCOPROTEIN; IN-VITRO; APOLIPOPROTEIN-E; A-BETA; NEURODEGENERATIVE DISEASES;
D O I
10.1016/j.bbrc.2013.11.059
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Altered brain cholesterol homeostasis plays a key role in neurodegenerative diseases such as Alzheimer's disease (AD). For a long time, the blood-brain barrier (BBB) was basically considered as a barrier isolating the brain from circulating cholesterol, however, several lines of evidence now suggest that the BBB strictly regulates the exchanges of sterol between the brain and the peripheral circulation. Oxysterols, synthesized by neurons or by peripheral cells, cross the BBB easily and modulate the expression of several enzymes, receptors and transporters which are involved not only in cholesterol metabolism but also in other brain functions. This review article deals with the way oxysterols impact BBB cells. These perspectives open new routes for designing certain therapeutical approaches that target the BBB so that the onset and/or progression of brain diseases such as AD may be modulated. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:687 / 691
页数:5
相关论文
共 50 条
  • [1] Role of Blood-Brain Barrier in Alzheimer's Disease
    Cai, Zhiyou
    Qiao, Pei-Feng
    Wan, Cheng-Qun
    Cai, Min
    Zhou, Nan-Kai
    Li, Qin
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 63 (04) : 1223 - 1234
  • [2] The Case for Blood-Brain Barrier Dysfunction in the Pathogenesis of Alzheimer's Disease
    Jeynes, Brian
    Provias, John
    JOURNAL OF NEUROSCIENCE RESEARCH, 2011, 89 (01) : 22 - 28
  • [3] Blood-brain barrier integrity in the pathogenesis of Alzheimer's disease
    Huang, Zhangsen
    Wong, Lik-Wei
    Su, Yixun
    Huang, Xiaomin
    Wang, Nan
    Chen, Hui
    Yi, Chenju
    FRONTIERS IN NEUROENDOCRINOLOGY, 2020, 59
  • [4] The blood-brain barrier in Alzheimer's disease
    Zenaro, Elena
    Piacentino, Gennj
    Constantin, Gabriela
    NEUROBIOLOGY OF DISEASE, 2017, 107 : 41 - 56
  • [5] Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease
    Erickson, Michelle A.
    Banks, William A.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2013, 33 (10) : 1500 - 1513
  • [6] Amyloid-β Peptides, Alzheimer's Disease and the Blood-brain Barrier
    Gosselet, Fabien
    Saint-Pol, Julien
    Candela, Pietra
    Fenart, Laurence
    CURRENT ALZHEIMER RESEARCH, 2013, 10 (10) : 1015 - 1033
  • [7] Addressing Blood-Brain Barrier Impairment in Alzheimer's Disease
    Sharma, Chanchal
    Woo, Hanwoong
    Kim, Sang Ryong
    BIOMEDICINES, 2022, 10 (04)
  • [8] Blood-Brain Barrier Breakdown in Alzheimer's Disease: Mechanisms and Targeted Strategies
    Alkhalifa, Amer E.
    Al-Ghraiybah, Nour F.
    Odum, Julia
    Shunnarah, John G.
    Austin, Nataleigh
    Kaddoumi, Amal
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
  • [9] Treatment of Alzheimer's Disease and Blood-Brain Barrier Drug Delivery
    Pardridge, William M.
    PHARMACEUTICALS, 2020, 13 (11) : 1 - 25
  • [10] Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease
    Bell, Robert D.
    Zlokovic, Berislav V.
    ACTA NEUROPATHOLOGICA, 2009, 118 (01) : 103 - 113